Possibility Neurotechnologies
Headquarters: Alberta
Summary
Possibility Neurotechnologies is commercializing Think2Switch™—a mobile, brain-computer interface platform enabling people with limited mobility to control technology using brain activity. We are seeking Korean partners for hardware integration, enterprise distribution, clinical validation, and joint R&D, with particular interest in rehabilitation robotics, connected technologies, digital health, and EEG hardware. We are also open to strategic investment discussions as part of our current Seed raise.
About
Possibility Neurotechnologies is a Canadian neurotechnology company developing accessible brain-computer interface (BCI) solutions for individuals with severe physical disabilities and complex communication needs. Our flagship product, Think2Switch™, enables users to control switch-accessible devices, software, communication tools, mobility devices, and smart technologies using brain signals captured from commercially available EEG headsets. The company was founded based on a decade of research conducted through the University of Calgary’s BCI4Kids Program, one of the world’s leading pediatric brain-computer interface programs. Think2Switch™ has been used by more than 200 families and 20 clinical sites and has accumulated over 5,000 hours of real-world use. The platform is commercially available through the Apple App Store and is currently being deployed across Canada, USA, Australia, and other international markets. Possibility Neurotechnologies is seeking strategic partnerships in rehabilitation, assistive technology, neurotechnology, digital health, and disability services. Areas of interest include collaborative R&D, clinical validation, telehealth integration, rehabilitation applications, communication technologies, and expansion into Asian markets. We are particularly interested in connecting with hospitals, rehabilitation centres, universities, disability service organizations, assistive technology companies, robotics companies, and investors focused on social impact, neurotechnology and digital health innovation.